Cargando…

Neue Behandlungsoption bei COVID-19

Detalles Bibliográficos
Autor principal: Facharztmagazine, Redaktion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576310/
https://www.ncbi.nlm.nih.gov/pubmed/36253704
http://dx.doi.org/10.1007/s15006-022-2012-7
_version_ 1784811496553840640
author Facharztmagazine, Redaktion
author_facet Facharztmagazine, Redaktion
author_sort Facharztmagazine, Redaktion
collection PubMed
description
format Online
Article
Text
id pubmed-9576310
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-95763102022-10-18 Neue Behandlungsoption bei COVID-19 Facharztmagazine, Redaktion MMW Fortschr Med Pharmaforum Springer Medizin 2022-10-18 2022 /pmc/articles/PMC9576310/ /pubmed/36253704 http://dx.doi.org/10.1007/s15006-022-2012-7 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Pharmaforum
Facharztmagazine, Redaktion
Neue Behandlungsoption bei COVID-19
title Neue Behandlungsoption bei COVID-19
title_full Neue Behandlungsoption bei COVID-19
title_fullStr Neue Behandlungsoption bei COVID-19
title_full_unstemmed Neue Behandlungsoption bei COVID-19
title_short Neue Behandlungsoption bei COVID-19
title_sort neue behandlungsoption bei covid-19
topic Pharmaforum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576310/
https://www.ncbi.nlm.nih.gov/pubmed/36253704
http://dx.doi.org/10.1007/s15006-022-2012-7
work_keys_str_mv AT facharztmagazineredaktion neuebehandlungsoptionbeicovid19